JP2023538144A5 - - Google Patents
Info
- Publication number
- JP2023538144A5 JP2023538144A5 JP2023512783A JP2023512783A JP2023538144A5 JP 2023538144 A5 JP2023538144 A5 JP 2023538144A5 JP 2023512783 A JP2023512783 A JP 2023512783A JP 2023512783 A JP2023512783 A JP 2023512783A JP 2023538144 A5 JP2023538144 A5 JP 2023538144A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063068944P | 2020-08-21 | 2020-08-21 | |
| US63/068,944 | 2020-08-21 | ||
| PCT/US2021/047203 WO2022040641A2 (en) | 2020-08-21 | 2021-08-23 | Functional ionizable phospholipids |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023538144A JP2023538144A (ja) | 2023-09-06 |
| JP2023538144A5 true JP2023538144A5 (https=) | 2024-11-05 |
| JPWO2022040641A5 JPWO2022040641A5 (https=) | 2024-11-05 |
| JP7849049B2 JP7849049B2 (ja) | 2026-04-21 |
Family
ID=80323210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512783A Active JP7849049B2 (ja) | 2020-08-21 | 2021-08-23 | 機能性のイオン化可能なリン脂質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230320994A1 (https=) |
| EP (1) | EP4199934A4 (https=) |
| JP (1) | JP7849049B2 (https=) |
| CN (1) | CN117355335A (https=) |
| AU (1) | AU2021327782A1 (https=) |
| CA (1) | CA3189905A1 (https=) |
| WO (1) | WO2022040641A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024511463A (ja) * | 2021-03-22 | 2024-03-13 | リコード セラピューティクス，インク． | 細胞への標的送達のための組成物および方法 |
| JP2024511437A (ja) | 2021-03-23 | 2024-03-13 | リコード セラピューティクス，インク． | ポリヌクレオチド組成物、関連製剤、およびその使用方法 |
| WO2023218420A1 (en) | 2022-05-13 | 2023-11-16 | Janssen Pharmaceuticals, Inc. | Mrna compositions for inducing latent hiv-1 reversal |
| EP4385523A1 (en) * | 2022-12-14 | 2024-06-19 | Beijing Jitai Pharmaceutical Technology Co., Ltd. | Lipid-based topical injection formulations |
| WO2024124660A1 (zh) * | 2022-12-14 | 2024-06-20 | 北京剂泰医药科技有限公司 | 脂质基质局部注射制剂 |
| KR20250124204A (ko) * | 2022-12-23 | 2025-08-19 | 턴 바이오테크놀로지스 인코포레이티드 | 이중 지질 구조 |
| EP4680595A2 (en) | 2023-03-15 | 2026-01-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2024192291A1 (en) | 2023-03-15 | 2024-09-19 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| WO2024250133A1 (zh) * | 2023-06-05 | 2024-12-12 | 安徽医科大学第一附属医院 | 肺靶向纳米胶束、制备方法及应用 |
| CN117180196B (zh) * | 2023-08-09 | 2025-11-18 | 福建师范大学 | 一种抗原适配型的疫苗佐剂体系及其在制备新冠和猴痘疫苗中的应用 |
| WO2025128871A2 (en) | 2023-12-13 | 2025-06-19 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2025155753A2 (en) | 2024-01-17 | 2025-07-24 | Renagade Therapeutics Management Inc. | Improved gene editing system, guides, and methods |
| WO2025166238A1 (en) | 2024-01-31 | 2025-08-07 | Orna Therapeutics, Inc. | Fast-shedding polyethylene glycol lipids |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774350A (en) * | 1985-08-30 | 1988-09-27 | Kao Corporation | Phosphoric ester |
| DE4111105A1 (de) * | 1991-04-05 | 1992-10-08 | Max Planck Gesellschaft | Neue erucyl-, brassidyl- und nervonylderivate |
| JPH06157560A (ja) * | 1992-11-26 | 1994-06-03 | Toyo Ink Mfg Co Ltd | リン脂質系界面活性剤及びその製造方法 |
| AU9263298A (en) | 1997-08-18 | 1999-03-08 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Phospholipid analogue compounds |
| ATE371680T1 (de) * | 2002-01-16 | 2007-09-15 | Biocompatibles Uk Ltd | Polymerkonjugate |
| DE10207178A1 (de) | 2002-02-19 | 2003-09-04 | Novosom Ag | Komponenten für die Herstellung amphoterer Liposomen |
| UA99434C2 (ru) * | 2005-12-19 | 2012-08-27 | Аетерна Центаріс Гмбх | Применение производных алкилфосфолипидов со сниженной цитотоксичностью |
| DE102006028983A1 (de) | 2006-06-23 | 2007-12-27 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Phosphorsäurediesteramide |
| JP5488121B2 (ja) | 2010-03-31 | 2014-05-14 | 日油株式会社 | 経皮吸収促進及び／又は保湿性向上作用を示す剤、並びに化粧料 |
| FR2966727B1 (fr) * | 2010-11-03 | 2013-04-12 | Oreal | Utilisation comme antipelliculaire de polymeres phospholipidiques |
| FR2990206B1 (fr) * | 2012-05-07 | 2014-06-06 | Commissariat Energie Atomique | Nouveaux composes bifonctionnels utiles comme ligands de l'uranium(vi), leurs procedes de synthese et leurs utilisations |
| WO2017059057A1 (en) * | 2015-09-30 | 2017-04-06 | The Regents Of The University Of California | Nano-adhesive and surface primer compound and use thereof |
| HRP20220652T1 (hr) * | 2015-12-10 | 2022-06-24 | Modernatx, Inc. | Pripravci i postupci unosa terapijskih sredstava |
| CA3024129A1 (en) | 2016-05-16 | 2017-11-23 | The Board Of Regents Of The University Of Texas System | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids |
-
2021
- 2021-08-23 AU AU2021327782A patent/AU2021327782A1/en active Pending
- 2021-08-23 WO PCT/US2021/047203 patent/WO2022040641A2/en not_active Ceased
- 2021-08-23 US US18/042,390 patent/US20230320994A1/en active Pending
- 2021-08-23 JP JP2023512783A patent/JP7849049B2/ja active Active
- 2021-08-23 EP EP21859283.0A patent/EP4199934A4/en active Pending
- 2021-08-23 CA CA3189905A patent/CA3189905A1/en active Pending
- 2021-08-23 CN CN202180069932.XA patent/CN117355335A/zh active Pending